Aspira Women's Health Inc. 8-K

What Happened
Aspira Women’s Health Inc. announced that it published an investor presentation on its website on December 29, 2025 and furnished that slide deck as Exhibit 99.1 in a Form 8-K filed on December 31, 2025. The disclosure was made under Item 7.01 (Regulation FD Disclosure). The filing was signed by CEO Michael Buhle.

Key Details

• Presentation published: December 29, 2025 on the company website.
• 8-K filed: December 31, 2025; slide deck furnished as Exhibit 99.1.
• Regulation FD: Disclosure made under Item 7.01 (broad public dissemination).
• Signature: Form 8-K signed by Michael Buhle, Chief Executive Officer.

Why It Matters
This filing informs investors that Aspira has publicly shared updated investor materials; investors should review the slide deck for any new business updates or guidance. The 8-K does not itself report earnings, executive changes, or transaction terms — it simply furnishes the presentation under Regulation FD for broad distribution.